Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial

2013 ◽  
Vol 24 (4) ◽  
pp. 561-566 ◽  
Author(s):  
Takahiko Kurasawa ◽  
Hayato Nagasawa ◽  
Mayumi Kishimoto ◽  
Koichi Amano ◽  
Tsutomu Takeuchi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Disease Modifying ◽  
Rheumatic Drug

scholarly journals Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial

2019 ◽  
Vol 102 (5) ◽  
pp. 976-983 ◽  
Author(s):  
Allison A. Marshall ◽  
Alessandra Zaccardelli ◽  
Zhi Yu ◽  
Maria G. Prado ◽  
Xinyi Liu ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Rheumatoid Arthritis Risk ◽  
Randomized Controlled

Physical Activity to Reduce Fatigue in Rheumatoid Arthritis: A Randomized Controlled Trial

2017 ◽  
Vol 70 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Patricia Katz ◽  
Mary Margaretten ◽  
Steven Gregorich ◽  
Laura Trupin
Keyword(s):  
Rheumatoid Arthritis ◽  
Physical Activity ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document